IL1B and rheumatoid arthritis: Indeed, we found that blocking IL‐1β using the IL‐1Ra improved atherosclerotic lesion regression, as evidenced by a reduction in lipid‐laden plaque macrophages and an increase in collagen deposition in a pre‐clinical model of RA.